{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:02Z","timestamp":1791895442266,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cca.2019.06.019","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T18:46:22Z","timestamp":1561056382000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":276,"special_numbering":"C","title":["Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes"],"prefix":"10.1016","volume":"496","author":[{"given":"Priya","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Lent-Schochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwarlal","family":"Jialal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.06.019_bb0005","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.cca.2019.06.019_bb0010","article-title":"Subcutaneous adipose tissue biology in metabolic syndrome","volume":"33","author":"Jialal","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.cca.2019.06.019_bb0015","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2019.06.019_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/gerona\/63.4.414","article-title":"The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity","volume":"63","author":"Nicklas","year":"2008","journal-title":"J. Gerontol. Ser. A."},{"key":"10.1016\/j.cca.2019.06.019_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-019-01052-3","article-title":"Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation","author":"Barchetta","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cca.2019.06.019_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/ijms.13800","article-title":"Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west Virginian population","volume":"13","author":"Srikanthan","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cca.2019.06.019_bb0035","first-page":"1","article-title":"Adipose tissue dysregulation in patients with metabolic syndrome","volume":"314","author":"Bremer","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0040","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2006-0361","article-title":"Reduced plasma visfatin\/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans","volume":"91","author":"Pagano","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1365-2265.2007.02966.x","article-title":"Circulating visfatin level is correlated with inflammation, but not with insulin resistance","volume":"67","author":"Oki","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2019.06.019_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1126\/science.1188280","article-title":"Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity","volume":"329","author":"Ouchi","year":"2010","journal-title":"Science."},{"key":"10.1016\/j.cca.2019.06.019_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diabres.2012.11.026","article-title":"Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance","volume":"99","author":"Hu","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2019.06.019_bb0060","doi-asserted-by":"crossref","first-page":"E504","DOI":"10.1152\/ajpendo.00462.2018","article-title":"Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis","volume":"316","author":"Gurung","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0065","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.06.019_bb0070","volume":"6","author":"Zachariah","year":"2017","journal-title":"J. Am. Heart Assoc. [Internet]"},{"key":"10.1016\/j.cca.2019.06.019_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2015.04.814","article-title":"Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome","volume":"241","author":"Jialal","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.cca.2019.06.019_bb0080","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s00125-013-3015-9","article-title":"A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction","volume":"56","author":"Moreno-Navarrete","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2019.06.019_bb0085","doi-asserted-by":"crossref","DOI":"10.1515\/hmbci-2018-0015","article-title":"Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome","author":"Lent-Schochet","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.cca.2019.06.019_bb0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jdiacomp.2018.05.014","article-title":"Exploratory lipidomics in patients with nascent metabolic syndrome","volume":"32","author":"Ramakrishanan","year":"2018","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.cca.2019.06.019_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jdiacomp.2018.02.005","article-title":"Amino acid levels in nascent metabolic syndrome: a contributor to the pro-inflammatory burden","volume":"32","author":"Reddy","year":"2018","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.cca.2019.06.019_bb0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jdiacomp.2018.12.002","article-title":"Exploratory metabolomics of nascent metabolic syndrome","volume":"33","author":"Shim","year":"2019","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.cca.2019.06.019_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.03.030","article-title":"Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases","author":"Francisco","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cca.2019.06.019_bb0110","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.06.019_bb0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","article-title":"Adiponectin--a key adipokine in the metabolic syndrome","volume":"8","author":"Whitehead","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0120","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2019.06.019_bb9086","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1373\/clinchem.2008.108886","article-title":"The evolving role of C-reactive protein in atherothrombosis","volume":"55","author":"Devaraj","year":"2009","journal-title":"Clinical chemistry"},{"key":"10.1016\/j.cca.2019.06.019_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOL.0b013e32832ac03e","article-title":"Human C-reactive protein and the metabolic syndrome","volume":"20","author":"Devaraj","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cca.2019.06.019_bb0130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2337\/diacare.28.4.878","article-title":"The metabolic syndrome and concentrations of C-reactive protein among U.S. youth","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2019.06.019_bb0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.cca.2019.06.019_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.33549\/physiolres.930000.53.229","article-title":"Quantification of intra-abdominal fat during controlled weight reduction: assessment using the water-suppressed breath-hold MRI technique","volume":"53","author":"Tintera","year":"2004","journal-title":"Physiol. Res."},{"key":"10.1016\/j.cca.2019.06.019_bb0145","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.2337\/dc09-0176","article-title":"Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people","volume":"32","author":"Lapice","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2019.06.019_bb0150","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.cca.2019.06.019_bb0155","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.cca.2019.06.019_bb0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/me.2006-0354","article-title":"C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase","volume":"21","author":"Xu","year":"2007","journal-title":"Mol. Endocrinol. (Baltimore, MD)"},{"key":"10.1016\/j.cca.2019.06.019_bb0165","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00125-006-0522-y","article-title":"C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport","volume":"50","author":"D'Alessandris","year":"2007","journal-title":"Diabetologia."},{"key":"10.1016\/j.cca.2019.06.019_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.2600","article-title":"An update on the role of markers of inflammation in atherosclerosis","volume":"17","author":"Corrado","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cca.2019.06.019_bb0175","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.cca.2019.06.019_bb0180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/qjmed\/hcg129","article-title":"Fibrinogen: biochemistry, epidemiology and determinants","volume":"96","author":"Kamath","year":"2003","journal-title":"QJM."},{"key":"10.1016\/j.cca.2019.06.019_bb0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0038-1650240","article-title":"Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton","volume":"75","author":"van de Stolpe","year":"1996","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.06.019_bb0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diacare.21.4.649","article-title":"Plasma fibrinogen: a new factor of the metabolic syndrome: A population-based study","volume":"21","author":"Imperatore","year":"1998","journal-title":"Diabetes Care."},{"key":"10.1016\/j.cca.2019.06.019_bb0195","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0026-0495(98)90307-9","article-title":"Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects","volume":"47","author":"Fendri","year":"1998","journal-title":"Metabolism."},{"key":"10.1016\/j.cca.2019.06.019_bb0200","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0038-1646997","article-title":"Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2","volume":"60","author":"Alessi","year":"1988","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2019.06.019_bb0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-9877(80)90108-5","article-title":"Fatty acids, fibrinogen and blood flow: a general mechanism for hyperfibrinogenemia and its pathologic consequences","volume":"6","author":"Pickart","year":"1980","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.cca.2019.06.019_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2008.03.054","article-title":"Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels","volume":"135","author":"Onat","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2019.06.019_bb0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5551\/jat.1529","article-title":"Associations of fibrinogen with metabolic syndrome in rural Chinese population","volume":"17","author":"Ma","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cca.2019.06.019_bb0220","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1371\/journal.pmed.0030287","article-title":"Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications","volume":"3","author":"Yang","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cca.2019.06.019_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/793628","article-title":"Serum amyloid A as a marker of persistent inflammation and an Indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis","volume":"2014","author":"Targo\u0144ska-St\u0119pniak","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2019.06.019_bb0230","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1210\/jc.2007-2491","article-title":"The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin","volume":"93","author":"Natal","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"156","key":"10.1016\/j.cca.2019.06.019_bb0235","first-page":"3952","article-title":"Activation of human monocytes through CD40 induces matrix metalloproteinases","volume":"1950","author":"Malik","year":"1996","journal-title":"J. Immunol. (Baltimore MD)"},{"key":"10.1016\/j.cca.2019.06.019_bb0240","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2019.06.019_bb0245","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0021-9150(97)00309-2","article-title":"CD40 signaling in vascular cells: a key role in atherosclerosis?","volume":"137","author":"Mach","year":"1998","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.cca.2019.06.019_bb0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Cell Mol. Life Sci. CMLS"},{"key":"10.1016\/j.cca.2019.06.019_bb0255","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/dc11-2375","article-title":"Increased toll-like receptor activity in patients with metabolic syndrome","volume":"35","author":"Jialal","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2019.06.019_bb0260","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/j.2047-6310.2012.00098.x","article-title":"Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents","volume":"8","author":"Hardy","year":"2013","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.cca.2019.06.019_bb0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20111708","article-title":"Role and function of macrophages in the metabolic syndrome","volume":"442","author":"Bhargava","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2019.06.019_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3945\/ajcn.116.148338","article-title":"Gut permeability, obesity, and metabolic disorders: who is the chicken and who is the egg?","volume":"105","author":"Fasano","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cca.2019.06.019_bb0275","first-page":"572","article-title":"Upregulation of monocyte tissue factor activity is significantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome","volume":"74","author":"Nakagomi","year":"2010","journal-title":"Circ. J. Off J. Jpn. Circ. Soc."},{"key":"10.1016\/j.cca.2019.06.019_bb0280","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/met.2014.0017","article-title":"Monocytes from metabolic syndrome subjects exhibit a proinflammatory M1 phenotype","volume":"12","author":"Chen","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.cca.2019.06.019_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000492778","article-title":"Serum lipopolysaccharide-binding protein is associated with chronic inflammation and metabolic syndrome in hemodialysis patients","volume":"47","author":"Lim","year":"2019","journal-title":"Blood Purif."},{"key":"10.1016\/j.cca.2019.06.019_bb0290","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/cen.12113","article-title":"Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial","volume":"79","author":"Loughrey","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2019.06.019_bb0295","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/jc.2016-2732","article-title":"Postprandial monocyte activation in individuals with metabolic syndrome","volume":"101","author":"Khan","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102088","article-title":"Chemokines from a structural perspective","volume":"18","author":"Miller","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2019.06.019_bb0305","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.06.019_bb0310","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.06.019_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/393192","article-title":"Adipose tissue dysfunction in nascent metabolic syndrome","volume":"2013","author":"Bremer","year":"2013","journal-title":"J. Obes."},{"key":"10.1016\/j.cca.2019.06.019_bb0320","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.medcli.2016.06.028","article-title":"Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population","volume":"147","author":"Guzm\u00e1n-Guzm\u00e1n","year":"2016","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.cca.2019.06.019_bb0325","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jdiacomp.2017.02.010","article-title":"The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome","volume":"31","author":"Pahwa","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"158","key":"10.1016\/j.cca.2019.06.019_bb0330","first-page":"376","article-title":"Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation","volume":"1950","author":"Gunn","year":"1997","journal-title":"J. Immunol. (Baltimore, MD)"},{"key":"10.1016\/j.cca.2019.06.019_bb0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2015.02.006","article-title":"Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance","volume":"21","author":"Kraakman","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0340","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.cca.2019.06.019_bb0345","doi-asserted-by":"crossref","first-page":"45777","DOI":"10.1074\/jbc.M301977200","article-title":"Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects","volume":"278","author":"Rotter","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cca.2019.06.019_bb0350","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism [Internet]"},{"key":"10.1016\/j.cca.2019.06.019_bb0355","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase","volume":"95","author":"Kern","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.06.019_bb0360","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.metabol.2014.12.009","article-title":"Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study","volume":"64","author":"Hoseini","year":"2015","journal-title":"Metabolism."},{"key":"10.1016\/j.cca.2019.06.019_bb0365","doi-asserted-by":"crossref","first-page":"w14446","DOI":"10.4414\/smw.2017.14446","article-title":"Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome","volume":"147","author":"Al-Shorman","year":"2017","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.cca.2019.06.019_bb0370","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/diabetes.55.01.06.db05-0751","article-title":"Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome","volume":"55","author":"Fortu\u00f1o","year":"2006","journal-title":"Diabetes."},{"key":"10.1016\/j.cca.2019.06.019_bb0375","doi-asserted-by":"crossref","first-page":"E1844","DOI":"10.1210\/jc.2012-2498","article-title":"Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome","volume":"97","author":"Jialal","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/17446651.2014.890046","article-title":"Dysregulation of monocyte biology in metabolic syndrome","volume":"9","author":"Jialal","year":"2014","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.06.019_bb0385","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/oby.2011.144","article-title":"Metabolic syndrome and acute hyperglycemia are associated with endoplasmic reticulum stress in human mononuclear cells","volume":"20","author":"Sage","year":"2012","journal-title":"Obesity."},{"key":"10.1016\/j.cca.2019.06.019_bb0390","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/ajh\/hpu021","article-title":"Alterations in neutrophil production and function at an early stage in the high-fructose rat model of metabolic syndrome","volume":"27","author":"Tagzirt","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2019.06.019_bb0395","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2019.06.019_bb0400","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0300060513516944","article-title":"Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus","volume":"42","author":"Sefil","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cca.2019.06.019_bb0405","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/met.2012.0179","article-title":"Increased neutrophil count in nascent metabolic syndrome","volume":"11","author":"Kaur","year":"2013","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.cca.2019.06.019_bb9087","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029612459675","article-title":"Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome","volume":"20","author":"Buyukkaya","year":"2014","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.cca.2019.06.019_bb0410","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jdiacomp.2016.08.006","article-title":"Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143)","volume":"30","author":"Surendar","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.cca.2019.06.019_bb0415","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1089\/dia.2013.0264","article-title":"Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes","volume":"16","author":"Shiny","year":"2014","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.cca.2019.06.019_bb0420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1076029615569568","article-title":"The relation between atherosclerosis and the neutrophil\u2013lymphocyte ratio","volume":"22","author":"Balta","year":"2016","journal-title":"Clin. Appl. Thromb."},{"key":"10.1016\/j.cca.2019.06.019_bb0425","first-page":"956","article-title":"Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease?","volume":"19","author":"Yasar","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cca.2019.06.019_bb0430","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/met.2017.0041","article-title":"Elevated neutrophil-to-lymphocyte ratio in metabolic syndrome is associated with increased risk of colorectal adenoma","volume":"15","author":"Kim","year":"2017","journal-title":"Metab. Syndr. Relat. Disord."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811931928X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811931928X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:47:55Z","timestamp":1757861275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811931928X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":88,"alternative-id":["S000989811931928X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.06.019","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}